Updated safety and clinical activity results from a phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC)
収録刊行物
-
- Annals of Oncology
-
Annals of Oncology 29 viii718-viii719, 2018-10
Elsevier BV